 |
Mushrooms are the fruiting bodies of a variety of fleshy fungi that are found worldwide. They typically appear suddenly from growing vegetative (mycelium) portions, and contain spores as reproductive units. Fungi lack chlorophyll; their nutritional requirements are met by utilizing organic material from a saprophytic, parasitic, and/or mycorrhizal life cycle.
Exposure is by ingestion. While most mushrooms are edible and safe, a few contain diverse secondary metabolites (cyclopeptides, monomethylhydrazine, orelline/orellanin, muscarine, ibotenic acid and muscimol, psilocybin, and unknowns) that on ingestion result in mild to severe illness and even death. The mushroom species most frequently implicated in human/animal mushroom fatalities globally is Amanita phalloides. Most Amanita species are typically identified by their physical characteristics—veil (universal/partial), cap or pileus (with scales—remnants of universal veil), lamellae (gill-like, spore-bearing structure under surface of pileus), spores (reproductive structure—white to black and other shades of color), stipe/stalk (cap support), annulus or ring (remnant of partial veil on stipe below pileus), volva (remnant of universal veil at base of bulb), and mycelium. Other characteristics helpful in the identification of some poisonous mushrooms are listed in see Poisonous Mushrooms: Physical Characteristics of Common Poisonous Mushrooms .
|
Table 1
|
PrintOpen table in new window  |
 |  |  |
| Physical Characteristics of Common Poisonous Mushrooms |
|
Name (Genus/Species)
|
Cap/Spores Color
|
Habitat
|
Season
|
Range
|
|
Amanita muscaria
|
Red-tan to yellow/orange/ white
|
Ground-pine, spruce, birch, poplar and oak trees
|
Autumn/ winter: June–Nov
|
Widespread, common in East and Calif
|
|
A pantherina
|
White with whitish patches; dark to yellow-brown at margin
|
Ground under conifers (Douglas fir)
|
Autumn/ winter: June, Sept–Oct Nov–Feb (Calif)
|
Rocky Mtns/West coast; rare in East
|
|
A phalloides
|
Yellow/green or green/white
|
Ground under conifers, hardwoods; junipers and oaks
|
Autumn: late Sept–Nov Nov–Jan
|
Mass. to Virginia west to Ohio; Pacific NW to Calif
|
|
A virosa
|
White/white
|
Ground; mixed woods; grass, near trees
|
Autumn: late June–early Nov
|
North America
|
|
Chlorophyllum molybdites
|
White/green or grayish white
|
Lawn, pastures, meadows, fairy rings
|
Summer: Aug–Sept
|
Florida to Calif, common in Denver. Reported in NY and NJ
|
|
Clitocybe spp
|
White/white
|
Ground
|
Perennial
|
Widespread in North America
|
|
Cortinarius orellanus
|
Orange/brown
|
Ground under conifers
|
July–Aug; Sept–Oct (Rocky Mtns) North
|
Widespread in North America
|
|
Galerina spp
|
Brown/rust-brown
|
Ground-wood, well decayed conifers and logs
|
Autumn/spring: Oct–Nov May–June
|
Throughout North America
|
|
Gyromitra esculenta
|
Brown-rust
|
Ground under conifers
|
Spring: April–early June
|
Throughout North America
|
|
Inocybe spp
|
Brown/bright rust/orange-brown or gray-brown
|
Ground
|
Autumn: May–Nov
|
Widespread in North America
|
|
Lepiota spp
|
White with brownish scales
|
Ground conifers, grass, leaf litter, oak and mixed woods
|
July–Oct (MI; OH); July–Nov (FL); Nov–Feb (Calif)
|
Throughout North America
|
|
Paxillus involutus
|
Brown
|
Ground: single/numerous on wood in mixed woods
|
July–Nov
|
Widespread in North America
|
|
Psilocybe cubensis
|
Brown/purple brown
|
Ground/wood/dung (cattle, horses)
|
Year round
|
Gulf Coast
|
|
Russula emetica
|
Reddish/white to yellowish white
|
Single/group; on sphagnum moss, rarely on very rotten wood, conifers or mixed woods
|
July–Sept
|
Widespread in North America
|
|
The time lapse (latent period) between ingestion and observed clinical signs in exposed animals by and large dictates the prognosis. Long delay time is synonymous with fatality (see Poisonous Mushrooms: Poisonous Mushrooms: Onset of Action and Organs Targeted ). Short latent periods do not always indicate non-lethality, because the animal may have ingested a combination of mushroom species. In mushroom species with clinical signs that appear <3 hr after ingestion, effects are generally self-limiting and not life-threatening. Those with clinical signs that appear >6 hr after ingestion are life-threatening.
|
Table 2
|
PrintOpen table in new window  |
 |  |  |
| Poisonous Mushrooms: Onset of Action and Organs Targeted |
|
Mushrooms
|
Toxin
|
Onset Time
|
Organ/System
|
|
|
|
|
|
Latent Period >6 hr Post-ingestion; Life-threatening
|
|
Amanita phalloides; A virosa
|
Cyclopeptides, α and β amanitins, phallotoxins, virotoxins
|
6–24 hr, rarely >24 hr
|
Primarily liver, kidney secondary
|
|
Conocybe filaris
|
α and β amanitins
|
6–14 hr, rarely >24 hr
|
Primarily liver
|
|
Cortinarius gentilis
|
Orellanin, orelline
|
3–14 days (days/weeks)
|
Primarily renala
|
|
Galerina autumnalis; G venenata
|
α and β amanitins
|
6–14 hr, rarely >24 hr
|
Primarily liver
|
|
Gyromitra esculenta
|
Monomethylhydrazine
|
6–24 hr
|
CNS
|
|
Lepiota spp
|
α and β amanitins
|
6–14 hr, rarely >24 hr
|
Primarily liver
|
|
|
|
|
|
Latent Period £3 hr Post-ingestion; not Life-threatening
|
|
Amanita muscaria; A pantherina
|
Isoxazoles: ibotenic acid muscimol
|
30 min–2 hr; recovery 4–24 hr
|
CNS
|
|
Chlorophyllum molybdites
|
Unknown
|
30 min–3 hr; recovery 1–2 days
|
GI
|
|
Clitocybe dealbata; Clitocybe spp; Inocybe spp
|
Muscarine
|
30 min–2 hr; recovery 6–24 hr
|
Autonomic nervous system
|
|
Paxillus involutus
|
Unknown
|
1–3 hr; recovery 2–4 days
|
Immune system
|
|
Psilocybe spp; Conocybe smithii; Gymnopilus spectabilis; Panaeolus subbalteatus
|
Psilocybin and psilocin
|
30–60 min; rarely 6 hr
|
CNS
|
|
Russula emetica
|
Unknown
|
30 min–3 hr; recovery 1–2 days
|
GI
|
|
a No reported veterinary cases
|
|
The sudden appearance of mushrooms and their short lifespan within the environment, coupled with the indiscriminate eating habits of many animals, creates diagnostic challenges. History and time post-ingestion at which clinical signs are observed determine the treatment approach and prognosis. Establishing the time of ingestion may be difficult to impossible. With no proven antidotes for treating mushroom poisonings, treatment is primarily directed at decontamination, mushroom identification when possible, and intensive supportive care.
Last full review/revision March 2012 by Cecil F. Brownie, DVM, PhD, DABVT, DABT, DABFE, DABFM, FACFEI
|  |
|